Key points are not available for this paper at this time.
to mammals. Finally, we demonstrate that both trBax and trBak BH3 peptides bind selectively to human Bcl-2 homologs to sensitize cancer cells to chemotherapy treatment.
Popgeorgiev et al. (Wed,) studied this question.